Logos Global Management »

Cybin Ord shares owned by Logos Global Management

Quarter-by-quarter ownership of Cybin Ord (CYBN) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Cybin Ord

Tip: Access up to 7 years of quarterly data

All positions including Cybin Ord held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cybin Ord by Logos Global Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $17M 40M 0.41

More positions owned by Logos Global Management

Sarepta Therapeutics (SRPT)
Alnylam Pharmaceuticals Call Option (ALNY)
Ideaya Biosciences (IDYA)
Immunocore Hldgs Ads (IMCR)
Immunovant (IMVT)
Ocular Therapeutix (OCUL)
Structure Therapeutics Sponsored Ads (GPCR)
Olema Pharmaceuticals (OLMA)
Dyne Therapeutics (DYN)
Apellis Pharmaceuticals (APLS)
Rocket Pharmaceuticals (RCKT)
Astria Therapeutics Call Option (ATXS)
Silence Therapeutics Ads (SLN)
Geron Corporation (GERN)
Annexon (ANNX)

View all positions for Logos Global Management

Top funds holding Cybin Ord

RA Capital Management
Logos Global Management
Avidity Partners Management
Sphera Funds Management
Octagon Capital Advisors
Rosalind Advisors
Altium Capital Management
Ikarian Capital
Point72 Asset Management
Alyeska Investment Group
AIGH Capital Management
Boothbay Fund Management
AWM Investment Company
AdvisorShares Investments
PDS Planning

View all funds holding Cybin Ord